arrow
L

Lars Klareskog

karolinska institutet
H指数:139
被引数:7.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications

类风湿关节炎中的弥漫大B细胞淋巴瘤表达结合蛋白质修饰的多反应性和自身反应性BCR

2026-10-270
OAAI
Increased CCL22 production in early rheumatoid arthritis development with potential impact on mucosal autoimmunity, joint inflammation and T cell recruitment to LAMP3+dendritic cells

早期类风湿关节炎发展过程中CCL22产生增加,可能对黏膜自身免疫、关节炎症及T细胞向LAMP3+树突状细胞的募集产生影响

2026-09-010
OAAI
Pan-disease blood protein profiles of rheumatic autoimmune diseases

风湿性自身免疫性疾病的泛疾病血液蛋白质谱

2026-07-130
OA
A human pan-disease blood atlas of the circulating proteome

循环蛋白质组的人类泛疾病血液图谱

SCIENCE
IF45.8
2025-12-183
PRE
WHO PARTICIPATES IN AN ONLINE SYMPTOM CHECKER? CHARACTERISTICS, ATTRITION AND REPRESENTATIVENESS IN THE RHEUMATIC? STUDY

谁参与了在线症状检查器?在风湿病研究中,其特征、流失率和代表性

2024-06-010
PRE
DIFFERENTIATION OF IMMUNE MEDIATED VERSUS NON IMMUNE MEDIATED RHEUMATIC DISEASES BY ONLINE SYMPTOM CHECKER IN REAL- WORLD PATIENTS - MULTIPLE DIAGNOSES AND PARTICULARLY FIBROMYALGIA IS A STUMBLING BLOCK

通过在线症状检查器区分免疫介导与非免疫介导的风湿病:真实世界患者中的多诊断问题,尤其是纤维肌痛症是障碍

2024-06-010
PRE
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

第三和第四剂新型冠状病毒肺炎疫苗在不同生物或靶向DMARDs的炎症性风湿性疾病患者中的血清学免疫原性: 瑞典全国研究 (COVID-19-REUMA)

2024-04-021
OAAI
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages

单克隆IgG向二聚体和分泌型IgA的转化可恢复中和能力并防止Omicron谱系的感染

2024-01-0913
OAAI